Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 269 papers

Liver transplantation in acute-on-chronic liver failure grade 3: Fifty shades of gray

Putignano A, Gustot T.

Liver Transpl 2022, 28(6): 933–935

DOI: 10.1002/lt.26440

Abnormal brain oxygen homeostasis in an animal model of liver disease

Hadjihambi A, Cudalbu C, Pierzchala K, Simicic D, Donnelly C, Konstantinou C, Davies N, Habtesion A, Gourine AV, Jalan R, Hosford PS.

JHEP Rep 2022, 4(8): 100509

DOI: 10.1016/j.jhepr.2022.100509

Hyperammonaemia induces mitochondrial dysfunction and neuronal cell death

Angelova PR, Kerbert AJC, Habtesion A, Hall A, Abramov AY, Jalan R.

JHEP Rep 2022, 4(8): 100510

DOI: 10.1016/j.jhepr.2022.100510

Transplantation in acute-on-chronic liver failure: Feasibility and futility

Queck A, Weiler N, Trebicka J.

Clin Liver Dis 2022, 19(5): 191–193

DOI: 10.1002/cld.1195

Acute-on-chronic liver failure (ACLF) precipitated by severe alcoholic hepatitis: Another collateral damage of the COVID-19 pandemic?

Görgülü E, Gu W, Trebicka J, Mücke VT, Muecke MM, Friedrich-Rust M, Bojunga J, Zeuzem S, Finkelmeier F, Peiffer KH.

Gut 2022, 71(5): 1036-1038

DOI: 10.1136/gutjnl-2021-325278

Prognostic role of liver biopsy in patients with severe indeterminate acute hepatitis

Lin S, Araujo C, Hall A, Kumar R, Phillips A, Hassan M, Engelmann C, Quaglia A, Jalan R.

Clin Gastroenterol Hepatol 2022, 20(5): 1130–1141

DOI: 10.1016/j.cgh.2021.08.008

Rectal colonization by resistant bacteria increases the risk of infection by the colonizing strain in critically ill patients with cirrhosis

Prado V, Hernández-Tejero M, Mücke MM, Marco F, Gu W, Amoros A, Toapanta D, Reverter E, Peña-Ramirez C, Altenpeter L, Bassegoda O, Mezzano G, Aziz F, Juanola A, Rodríguez-Tajes S, Chamorro V, López D, Reyes M, Hogardt M, Kempf VAJ, Ferstl PG, Zeuzem S, Martínez JA, Vila J, Arroyo V, Trebicka J, Fernandez J.

J Hepatol 2022, 76(5): 1079-1089

DOI: 10.1016/j.jhep.2021.12.042

Role of albumin in the treatment of decompensated liver cirrhosis

Trebicka J.

Curr Opin Gastroenterol 2022, 38(3): 200–205

DOI: 10.1097/MOG.0000000000000838

Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections

Bastida C, Hernández-Tejero M, Cariqueo M, Aziz F, Fortuna V, Sanz M, Brunet M, Fernández J, Soy D.

J Antimicrob Chemother 2022, 77(5): 1365–1371

DOI: 10.1093/jac/dkac036

Combination of fat-free muscle index and total spontaneous portosystemic shunt area identifies high-risk cirrhosis patients

Faron A, Abu-Omar J, Chang J, Böhling N, Sprinkart AM, Attenberger U, Rockstroh JK, Luu AM, Jansen C, Strassburg CP, Trebicka J, Luetkens J, Praktiknjo M.

Front Med (Lausanne) 2022, 9: 831005

DOI: 10.3389/fmed.2022.831005

Registered office

European Foundation for the Study of
Chronic Liver Failure
Travessera de Gràcia 11, 7th floor
08021 Barcelona, Spain

Legal

Contact us

T +34 93 227 14 00
E efclif@efclif.com

© European Foundation for the Study of Chronic Liver Failure 2024